Thyroiditis and COVID-19: focus on pediatric age. A narrative review
- PMID: 38457058
- DOI: 10.1007/s40618-024-02331-4
Thyroiditis and COVID-19: focus on pediatric age. A narrative review
Abstract
Purpose: In light of the growing concern over the possible link between SARS-CoV2 infection and autoimmune diseases, we conducted a review to investigate the impact of the pandemic outbreak on thyroid diseases.
Methods: We carried out a narrative review of all pediatric cases described in the literature, mainly focusing on the possible association of COVID-19 with the incidence of autoimmune and post-infective thyroid diseases (namely Hashimoto's Thyroiditis (HT), Grave's Disease (GD) and Sub-Acute Thyroiditis (SAT)). We also felt it was necessary to provide a brief review of Non-thyroidal Illness Syndrome (NTIS) and Multisystem Inflammatory Syndrome in Children (MIS-C) because of their overlap with thyroiditis.
Results: There is currently no conclusive evidence linking SARS-CoV-2 infection with an increased incidence of autoimmune thyroiditis (AT) in pediatric age. However, SAT may be a mild complication of SARS-CoV-2 infection, as is the case with other viral infections. SAT typically resolves on its own and does not require treatment. NTIS may be associated with inflammatory complications, such as MIS-C, and admission to intensive care. It may also be considered a prognostic risk factor for severe disease. The hypothesized pathogenetic mechanisms of thyroid damage in COVID-19 include direct damage due to the significant expression of angiotensin-converting enzyme 2 (ACE2) in the thyroid gland, which is a ligand for the virus, and indirect damage due to immune dysregulation, such as the overproduction of IL-6, which is thought to be part of the pathogenesis of thyroiditis.
Conclusion: However, due to the limited evidence available, further prospective longitudinal studies are required to clarify the relationship between COVID-19 and thyroid disease in children and adolescents, as well as to investigate any potential long-term consequences.
Keywords: Autoimmune diseases; COVID-19; Pediatric age; SARS-CoV2; Thyroid diseases; Thyroiditis.
© 2024. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
References
-
- Bettendorf M (2002) Thyroid disorders in children from birth to adolescence. Eur J Nucl Med Mol Imaging 29(Suppl 2):S439-446. https://doi.org/10.1007/s00259-002-0905-3 - DOI - PubMed
-
- Casto C, Pepe G, Li Pomi A et al (2021) Hashimoto’s thyroiditis and graves’ disease in genetic syndromes in pediatric age. Genes (Basel) 12:222. https://doi.org/10.3390/genes12020222 - DOI - PubMed
-
- Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348:2646–2655. https://doi.org/10.1056/NEJMra021194 - DOI - PubMed
-
- Tutal E, Ozaras R, Leblebicioglu H (2022) Systematic review of COVID-19 and autoimmune thyroiditis. Travel Med Infect Dis 47:102314. https://doi.org/10.1016/j.tmaid.2022.102314 - DOI - PubMed - PMC
-
- Yazdanpanah N, Rezaei N (2022) Autoimmune complications of COVID-19. J Med Virol 94:54–62. https://doi.org/10.1002/jmv.27292 - DOI - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous